CiteReady is an online personal knowledge management tool. Click to find out more!
5 of 12 articles - Show All
  1. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.

    Cancer cell , Volume 18 , Issue 1 (2010)
    Wang H , Vardy L A , Tan C P , Loo J M , Guo K , Li J , Lim S G , Zhou J , Chng W J , Ng S B , Li H X , Zeng Q
  2. PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

    JCI insight , Volume 1 , Issue 9 (2016)
    Thura M , Al-Aidaroos A Q , Yong W P , Kono K , Gupta A , Lin Y B , Mimura K , Thiery J P , Goh B C , Tan P , Soo R , Hong C W , Wang L , Lin S J , Chen E , Rha S Y , Chung H C , Li J , Nandi S , Yuen H F , Zhang S , Guan Y K , So J , Zeng Q
  3. Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans.

    Oncogene , Volume 35 , Issue 25 (2016)
    Wang H , Liu B , Al-Aidaroos A Q , Shi H , Li L , Guo K , Li J , Tan B C , Loo J M , Tang J P , Thura M , Zeng Q
  4. Targeting intracellular oncoproteins with antibody therapy or vaccination.

    Science translational medicine , Volume 3 , Issue 99 (2011)
    Guo K , Li J , Tang J P , Tan C P , Hong C W , Al-Aidaroos A Q , Varghese L , Huang C , Zeng Q
  5. Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice.

    Oncotarget , Volume 3 , Issue 2 (2012)
    Guo K , Tang J P , Jie L , Al-Aidaroos A Q , Hong C W , Tan C P , Park J E , Varghese L , Feng Z , Zhou J , Chng W J , Zeng Q
(No collections found)